Press release
California Breast Cancer Liquid Biopsy Market to grow at a CAGR of 23.2%, led by north America 44.6% global market share | key Players:- F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott, Agilent Technologies Inc.
Breast Cancer Liquid Biopsy
The market is growing due to rising breast cancer prevalence, increasing adoption of minimally invasive diagnostics, advancements in liquid biopsy technologies, faster detection of recurrence, strong investment in precision oncology, and growing clinical validation supporting liquid biopsy as an effective alternative to tissue biopsies.
Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/breast-cancer-liquid-biopsy-market?pratik
United States: Key Industry Developments
✅ October 2025: Guardant Health expanded its Guardant360 platform with enhanced ctDNA detection for breast cancer monitoring, improving sensitivity for early relapse detection in clinical trials.
✅ September 2025: New regulatory approvals advanced liquid biopsy assays for HER2 and BRCA mutation profiling, enabling better targeted therapy selection in metastatic breast cancer patients.
✅ April 2025: Guardant Health launched Guardant360 Tissue, offering multi-omic profiling of 742 DNA and 367 RNA genes from minimal tissue samples to support breast cancer liquid biopsy integration
Japan: Key Industry Developments
✅ September 2025: A Japanese clinical diagnostics company announced the rollout of an improved ctDNA breast cancer liquid biopsy test optimized for local population genomic profiles, enhancing detection of region-specific variants in metastatic breast cancer.
✅ March 2025: Japan's medical technology regulator updated guidance encouraging the use of liquid biopsy assays (including breast cancer) in routine oncology practice, which is expected to accelerate test deployment across hospital systems.
Breast Cancer Liquid Biopsy Market: 2025 FDA Approvals
→ Guardant360 CDx Expansion: FDA approved Guardant360 CDx as companion diagnostic for Eli Lilly's imlunestrant (Inluriyo) on September 25, 2025, detecting ESR1 mutations in ER+/HER2- advanced/metastatic breast cancer post-endocrine therapy.
The breast cancer liquid biopsy market report would provide approximately 51 tables, 54 figures, and 181 Pages.
"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=breast-cancer-liquid-biopsy-market?pratik ((Purchase 2 or more Repots and get 50% Discount)
Market Segmenatation-
→ By Product Type
Reagents & Kits - 60%
Largest share due to recurring test use and high demand for cfDNA/ctDNA and multi-analyte panels.
Instruments - 40%
Driven by NGS, digital PCR, and CTC platform adoption, though replacement cycles are slower.
→ By Circulating Biomarkers
cfDNA/ctDNA - 50%
Dominant segment used for mutation profiling, MRD monitoring, and companion diagnostics.
CTCs - 25%
Widely used in metastatic breast cancer for prognostic and monitoring purposes.
Extracellular Vesicles (Exosomes) - 15%
Growing in research and early clinical applications for miRNA and protein signatures.
Other Biomarkers - 10%
Includes circulating RNA, proteins, and multi-omic assays in early-stage development.
→ By Application
Clinical Diagnostics - 55%
Strong use in treatment selection, monitoring, and MRD assessment in breast cancer.
Research Applications - 30%
Driven by biomarker discovery, drug development, and translational oncology programs.
Early Detection & Screening - 15%
Emerging segment supported by advanced multi-omic early-screening technologies.
Regional Insights (2025)
→ North America: 44.6% of the global market the largest share due to advanced healthcare systems, high adoption of liquid biopsy technologies, and strong research & diagnostics infrastructure.
→ Europe: 26.8%% share significant growth driven by widespread cancer screening programs, strong regulatory support, and established diagnostic companies.
→ Asia Pacific: 15%% share rapidly expanding with rising breast cancer incidence, increasing healthcare investments, and growing adoption of precision diagnostics in countries like China, India, and Japan.
→ Latin America: 5%% share driven by expanding healthcare access and rising awareness in key markets such as Brazil and Mexico.
Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/breast-cancer-liquid-biopsy-market?pratik
Key Market Drivers -
Demand for minimally-invasive testing patients and clinicians prefer blood tests over tissue biopsies for safety and repeat monitoring.
Rising breast-cancer incidence and screening efforts increase testing volumes worldwide.
Precision medicine & targeted therapies: liquid biopsies guide therapy selection and track resistance mutations in real time.
Rapid technological advances (NGS, ctDNA/CTC assays, bioinformatics) improve sensitivity and clinical utility.
Growing use in treatment monitoring, minimal residual disease (MRD) detection and recurrence surveillance expands clinical applications.
Regulatory & reimbursement progress in some regions is making tests more accessible (pilot rollouts and guideline adoption)
Market Companies
F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott, Agilent Technologies Inc., Merck KGaA, Cell Signaling Technology Inc., Medtronic, Bio-Rad Laboratories Inc., ExoDx, and Biocept Inc.
1. How big is the Breast Cancer Liquid Biopsy Market ?
Global Breast Cancer Liquid Biopsy Market reached US$ 1.6 billion in 2023 and is expected to reach US$ 7.98 billion by 2031
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release California Breast Cancer Liquid Biopsy Market to grow at a CAGR of 23.2%, led by north America 44.6% global market share | key Players:- F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott, Agilent Technologies Inc. here
News-ID: 4312988 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Vinyl Acetate Monomer Market Outlook: Supply Dynamics & Industrial Growth in GCC …
Vinyl Acetate Monomer Market reached US$ 10.2 billion in 2023 and is expected to reach US$ 15.7 billion by 2031, growing with a CAGR of 4.5% during the forecast period 2024-2031.
Get Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/vinyl-acetate-monomer-market?kb
United States: Recent Industry Developments
✅ November 2025: Celanese Corporation announced capacity optimization initiatives to strengthen the domestic VAM supply chain and support adhesives, coatings, and packaging…
United States Tungsten Carbide Market Insights: Advanced Material Use Across Key …
Tungsten Carbide Market reached USD$ 20.2 billion in 2022 and is expected to reach USD$ 34.7 billion by 2031, growing with a CAGR of 7.0% during the forecast period 2024-2031.
Get Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/tungsten-carbide-market?kb
United States: Recent Industry Developments
✅ November 2025: U.S.-based manufacturers expanded tungsten carbide tool production to support rising demand in aerospace and precision machining.
✅ October 2025: New…
United States Plant-based Probiotics Market to hit US$ 1382.3 million, led by No …
Plant-based Probiotics Market reached US$ 912.1 million in 2023 and is expected to reach US$ 1382.3 million by 2031, growing with a CAGR of 6.1% during the forecast period 2024-2031.
The Global Plant-Based Probiotics Market is growing due to rising consumer awareness of gut health, increasing demand for natural and vegan supplements, expansion of functional foods and beverages, and a shift toward healthier, sustainable lifestyle choices worldwide.
Download your exclusive sample report…
United States Polyurea Coating Market Set for Rapid Growth to hit US$2.46 Billio …
Polyurea Coating Market reached US$ 1.42Billionin 2024 and is expected to reach US$2.46 Billion by 2032, growing at a CAGR of 7.12% during the forecast period 2025-2032.
Get Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/polyurea-coatings-market?kb
United States: Recent Industry Developments
✅ November 2025: Leading U.S. coating manufacturers introduced fast-curing polyurea systems designed for large-scale infrastructure rehabilitation.
✅ October 2025: New polyurea formulations with enhanced chemical resistance gained…
More Releases for Breast
Breast Health Monitoring App Market to Witness a Pronounce Growth during 2024-20 …
The latest market intelligence report published by WMR with the title "Global Breast Health Monitoring App Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Healthcare and Pharmaceuticals industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Breast Health Monitoring App Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y…
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer …
FOR IMMEDIATE RELEASE
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer During Breast Cancer Awareness Month
Liverpool, UK - October, 2023 - Phil Alderson, a primary survivor of male breast cancer, is taking bold steps this Breast Cancer Awareness Month to raise awareness of this often overlooked aspect of the disease. With a homemade cardboard sign that reads "Check Your Pecks," Phil has taken to the streets of…
Breast Health Monitoring App Market Recent Trends, In-depth Analysis, Size, and …
According to The Worldwide Market Reports, the Latest research report on "Breast Health Monitoring App Market Size, Revenue, Global Analysis, and Forecast 2023 to 2030" The Breast Health Monitoring App Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore,…
Breast Pumps Market - Nurturing Convenience: Revolutionizing Breast Pump Technol …
Newark, New Castle, USA - new report, titled Breast Pumps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Breast Pumps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Breast Pumps market. The report offers an overview of the market, which…
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues.
Download Free PDF Brochure on Brest Imaging Market Report Now…
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to…
